Sectors

Hewlett-Packard Enterprise is set to exit the containerised application security provider in a purchase of undisclosed size by Red Hat.

Cambrian Biopharma returned to back the immunotherapy developer's series B round, following its series A three months ago.

ADM Ventures, GV and Barclays helped the microbe-based protein developer close a round that will support research and development.

Rich Products Ventures has helped the meal delivery service secure $10.3m to hike its overall funding to $26m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Orange Ventures has been spun off into an independent venture firm with an extra $426m from its former parent company, and added Mathieu de La Rochefoucauld as managing partner.

GV and Nextech contributed to a series B round that boosted the affordable pharmaceutical developer's overall funding to $750m.

Hepalink will exit the immune and inflammatory disease drug developer in an acquisition that could reach $1.45bn in size.

The brain disease treatment developer was founded in 2019 on the back of more than a decade’s collaborative research from MIT and Harvard.

Microsoft, PayU and Boston Consulting Group are among the investors in digital currency platform developer Bakkt, which will list in a reverse merger set to value it at $2.1bn.

Temporary staffing portal Jobandtalent has added $108m to its latest round from investors including Seek to take its total funding to roughly $290m.